Correction to: Severity distribution and treatment of chronic obstructive pulmonary disease in China: baseline results of an observational study

Ting Yang^{1

2}, Baiqiang Cai³, Bin Cao^{1

2}, Jian Kang⁴, Fuqiang Wen⁵, Yahong Chen⁶, Wenhua Jian⁷, Hongyan Shang⁸, Chen Wang^{9

10}

Affiliations

¹ Department of Pulmonary and Critical Care Medicine, China-Japan Friendship Hospital, Beijing, 100029, China.
² National Clinical Research Center for Respiratory Diseases, Beijing, 100029, China.
³ Department of Respiratory and Critical Care Medicine, Peking Union Medical College Hospital, Beijing, China.
⁴ Department of Respiratory and Critical Care Medicine, The First Hospital of China Medical University, Shenyang, China.
⁵ Department of Respiratory and Critical Care Medicine, West China Hospital, Sichuan University, Chengdu, China.
⁶ Department of Respiratory and Critical Care Medicine, Peking University Third Hospital, Beijing, China.
⁷ State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Disease, National Clinical Research Center for Respiratory Disease, 1st Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
⁸ Department of Medical Affairs, AstraZeneca China, Shanghai, China.
⁹ Department of Pulmonary and Critical Care Medicine, China-Japan Friendship Hospital, Beijing, 100029, China. wangchen66366@163.com.
¹⁰ National Clinical Research Center for Respiratory Diseases, Beijing, 100029, China. wangchen66366@163.com.

Published Erratum

Ting Yang et al. Respir Res. 2022.

. 2022 Jun 18;23(1):159.

doi: 10.1186/s12931-022-02068-9.

Ting Yang^{1

2}, Baiqiang Cai³, Bin Cao^{1

2}, Jian Kang⁴, Fuqiang Wen⁵, Yahong Chen⁶, Wenhua Jian⁷, Hongyan Shang⁸, Chen Wang^{9

10}

¹ Department of Pulmonary and Critical Care Medicine, China-Japan Friendship Hospital, Beijing, 100029, China.
² National Clinical Research Center for Respiratory Diseases, Beijing, 100029, China.
³ Department of Respiratory and Critical Care Medicine, Peking Union Medical College Hospital, Beijing, China.
⁴ Department of Respiratory and Critical Care Medicine, The First Hospital of China Medical University, Shenyang, China.
⁵ Department of Respiratory and Critical Care Medicine, West China Hospital, Sichuan University, Chengdu, China.
⁶ Department of Respiratory and Critical Care Medicine, Peking University Third Hospital, Beijing, China.
⁷ State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Disease, National Clinical Research Center for Respiratory Disease, 1st Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
⁸ Department of Medical Affairs, AstraZeneca China, Shanghai, China.
⁹ Department of Pulmonary and Critical Care Medicine, China-Japan Friendship Hospital, Beijing, 100029, China. wangchen66366@163.com.
¹⁰ National Clinical Research Center for Respiratory Diseases, Beijing, 100029, China. wangchen66366@163.com.

No abstract available

Erratum for

Severity distribution and treatment of chronic obstructive pulmonary disease in China: baseline results of an observational study.
Yang T, Cai B, Cao B, Kang J, Wen F, Chen Y, Jian W, Shang H, Wang C. Yang T, et al. Respir Res. 2022 Apr 29;23(1):106. doi: 10.1186/s12931-022-02021-w. Respir Res. 2022. PMID: 35488337 Free PMC article.

1. Yang T, Cai B, Cao B, Kang J, Wen F, Chen Y, Jian W, Shang H, Wang C. Severity distribution and treatment of chronic obstructive pulmonary disease in China: baseline results of an observational study. Respir Res. 2022;23:106. doi: 10.1186/s12931-022-02021-w. - DOI - PMC - PubMed